Signal Dx Shifts Focus, Targets Amplification Technology for US Market | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Having an innovative technology means little if you can't get your products to your target audience. It's a lesson start-up molecular diagnostics firm Signal Diagnostic had to learn, and as a result, it is now recalibrating its business with a focus on the US and new targets for its technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.